Yumi Hiratani is a core member of Boston Consulting Group’s Health Care and Corporate Finance and Strategy practices.

Since joining BCG in 2002, Yumi has worked primarily with companies in the pharmaceutical and medtech industries. Within those industries she has rich experience in go-to-market strategy, new drug launch planning, sales force transformation, wholesaler and distribution strategy, pricing strategy, and cost optimization. She has also partnered with numerous clients on mid- and long-term strategy, growth strategy, post-merger integration, and transformation.


  • Pharmaceuticals and medtech
  • Sales and marketing strategy
  • Pricing
  • M&A
  • Business due diligence
  • Post-merger integration
  • Mid- and long- term strategy
  • New drug launch and pricing strategies
  • Transformation


  • MBA, Harvard School of Business
  • BA and MA, Hitotsubashi University
Deep Expertise, Broad Experience